Bitcoin (BTC) and cryptocurrencies are awaiting the Federal Reserve's January interest rate decision and a speech by FED Chairman Jerome Powell. Continue ReadingBitcoin (BTC) and cryptocurrencies are awaiting the Federal Reserve's January interest rate decision and a speech by FED Chairman Jerome Powell. Continue Reading

Bitcoin (BTC) and Markets Focus on the First FED Interest Rate Decision of the Year! What Time Will It Be Announced? Here Are the Expectations and Everything You Need to Know!

2026/01/28 23:33
3 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

In the Bitcoin (BTC) and cryptocurrency market, all eyes are on today’s FED meeting and the FED chairman’s statements.

Accordingly, the Fed will announce its first interest rate decision of 2026 tomorrow, followed by an oral statement from Fed Chairman Jerome Powell.

Following three consecutive interest rate cuts that began in September last year, the Fed is widely expected to keep interest rates unchanged in January. At this point, the Fed is expected to keep its policy interest rate range stable at 3.50–3.75 percent.

When Will the FED’s January Interest Rate Decision Be Announced?

The Fed will announce its January interest rate decision on January 28, 2026 at 10:00 PM Turkish time.

Following the decision, Federal Reserve Chairman Jerome Powell will make a verbal statement at 10:30 PM.

In Which Direction Are Expectations Focusing?

In the US, inflation hovering around 2.7% and signs of a slowdown in the job market are being interpreted as an indication that the Fed may adopt a cautious stance.

Related News: Journalist Nicknamed "FED Spokesperson" Speaks About the FED's January Interest Rate Decision! "The Decision is Clear, the Important Point is..."

Despite calls for interest rate cuts from US President Donald Trump and political pressure on Powell, the Fed is expected to continue making decisions in line with its goals of price stability and maximum employment.

However, Trump recently stressed the need to support economic growth, stating that a “meaningful reduction” in interest rates is essential.

Tim Duy, chief economist at SGH Macro Advisors, stated that Fed officials might adopt a “pause in interest rate cuts and reassess if data changes” approach, while Karim Basta, chief economist at III Capital Management, said Powell could signal that interest rates are “at a good level for now.”

Bloomberg economists Anna Wong and Chris Collins stated that pausing interest rate cuts could provoke new reactions from the White House.

Olu Sonola, head of US Economic Research at international credit rating agency Fitch Ratings, stated that current inflation and employment dynamics will keep the Fed on hold today.

Powell’s Statements Will Be Even More Important!

As expected, the Fed is anticipated to keep interest rates unchanged, but signals from the policy statement and Powell’s remarks are expected to influence market direction.

This meeting will also be very critical because it is the first meeting between the Fed and Powell following a subpoena issued in the past regarding building renovations.

Investors will be watching Powell’s press conference following the Fed’s decision to see if he leaves the door open for interest rate cuts in March and beyond.

Powell is also expected to comment on Trump’s political pressure on the Fed, central bank independence, and the steps he will take after his term ends in May.

At this point, Powell’s stance on inflation, growth, political pressures, and interest rate cuts will guide Bitcoin and the crypto market.

*This is not investment advice.

Continue Reading: Bitcoin (BTC) and Markets Focus on the First FED Interest Rate Decision of the Year! What Time Will It Be Announced? Here Are the Expectations and Everything You Need to Know!

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Condividi
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Condividi
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Condividi
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage